// App-Quantinova.ai

: A new lipid formulation of low dose (1200mg) ibuprofen is non-inferior to high dose (2400mg) standard ibuprofen capsules in managing episodic knee pain flares

Researchers

Presenter

  • S.M. Bierma-Zeinstra

Principal Investigators

  • J. Brew

  • R. Wilson

  • P.G. Conaghan

Medical Centers

  • Erasmus MC, Univ. Med. Ctr., Rotterdam, the Netherlands

  • Infirst Hlth.care, London, United Kingdom

  • Spica Consultants Ltd, Marlborough, United Kingdom

  • University of Leeds, Leeds, United Kingdom

Locations

  • Netherlands

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Cluster of differentiation 95

  • Nutritional risk screening

Drug/Treatment

  • Ibuprofen

Outcome

  • N/A

Study Design

  • Randomized

  • Non Inferiority

  • Multiple Arm

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved